Jul 21, 2026
(CNN)– It’s a legal battle between weight-loss drug heavyweights the maker of Wegovy is suing Zepbound manufacturer Eli Lilly. The lawsuit filed by Novo Nordisk says Eli Lilly’s advertising claims are deceptive. At issue are ads that say patients on Zepbound lost more weight than those taki ng Wegovy. Novo Nordisk is arguing those claims are based on comparing the highest doses of Zepbound to the lowest doses of its Wegovy. The company wants Eli Lilly to pull the ads and issue new ones with correct information. Categories: News Tags: Eli Lilly, GLP-1 weight loss drugs, Novo Nordisk, Wegovy, weight loss, weight loss drugs, Zepbound ...read more read less
Respond, make new discussions, see other discussions and customize your news...

To add this website to your home screen:

1. Tap tutorialsPoint

2. Select 'Add to Home screen' or 'Install app'.

3. Follow the on-scrren instructions.

Feedback
FAQ
Privacy Policy
Terms of Service